Skip to main content

A new model for ductal carcinoma in situ suggests strategies for treatment

Gullick, William J. (2002) A new model for ductal carcinoma in situ suggests strategies for treatment. Breast Cancer Research, 4 (5). pp. 176-178. ISSN 1465-5411. (doi:10.1186/bcr447) (KAR id:3986)

PDF (A New Model for Ductal Carcinoma )
Language: English
Download (93kB) Preview
[thumbnail of A New Model for Ductal Carcinoma ]
This file may not be suitable for users of assistive technology.
Request an accessible format
Official URL


Human ductal carcinoma in situ (DCIS) of the breast is now diagnosed quite frequently, due largely to the introduction of mammographic screening. It has been shown in a cell culture system that activation of c-erbB-2, but not the epidermal growth factor receptor, results in a DCIS-like phenotype. Since overexpression of c-erbB-2 occurs in 60% of DCIS, this suggests that it could be a target for treatment in this disease.

Item Type: Article
DOI/Identification number: 10.1186/bcr447
Additional information: Free full-text article in PubMed Central and on Breast Cancer Research.
Uncontrolled keywords: ductal carcinoma in situ, growth factor receptor, tyrosine kinase inhibitor
Subjects: Q Science
R Medicine > RC Internal medicine > RC254 Neoplasms. Tumors. Oncology
Divisions: Divisions > Division of Natural Sciences > School of Biosciences
Depositing User: William Gullick
Date Deposited: 04 Sep 2008 14:11 UTC
Last Modified: 16 Feb 2021 12:16 UTC
Resource URI: (The current URI for this page, for reference purposes)
  • Depositors only (login required):


Downloads per month over past year